| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.24e-07 | 262 | 49 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.57e-07 | 127 | 49 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.99e-06 | 37 | 49 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | helicase activity | 2.36e-06 | 158 | 49 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.08e-05 | 441 | 49 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.34e-05 | 645 | 49 | 9 | GO:0140640 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.75e-05 | 739 | 49 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 8.79e-05 | 6 | 49 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.13e-04 | 614 | 49 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | 5S rRNA binding | 5.27e-04 | 14 | 49 | 2 | GO:0008097 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 5.46e-04 | 775 | 49 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 9.18e-04 | 839 | 49 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 9.25e-04 | 840 | 49 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.25e-04 | 840 | 49 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.20e-03 | 21 | 49 | 2 | GO:0061676 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.71e-03 | 25 | 49 | 2 | GO:0048027 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 2.56e-03 | 111 | 49 | 3 | GO:0003727 | |
| GeneOntologyMolecularFunction | histone binding | 4.02e-03 | 265 | 49 | 4 | GO:0042393 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.35e-05 | 358 | 50 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.35e-05 | 358 | 50 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.53e-05 | 362 | 50 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 4.01e-05 | 79 | 50 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | ossification | 5.66e-05 | 562 | 50 | 8 | GO:0001503 | |
| GeneOntologyBiologicalProcess | sperm axoneme assembly | 7.61e-05 | 34 | 50 | 3 | GO:0007288 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.96e-04 | 502 | 50 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 2.29e-04 | 515 | 50 | 7 | GO:0022613 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 3.05e-04 | 244 | 50 | 5 | GO:0022618 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 3.16e-04 | 917 | 50 | 9 | GO:0016071 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 3.39e-04 | 56 | 50 | 3 | GO:0120316 | |
| GeneOntologyBiologicalProcess | mRNA processing | 3.45e-04 | 551 | 50 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 3.67e-04 | 254 | 50 | 5 | GO:0071826 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 4.20e-04 | 145 | 50 | 4 | GO:0001578 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 5.27e-04 | 275 | 50 | 5 | GO:0016072 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 5.80e-04 | 158 | 50 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 5.90e-04 | 999 | 50 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | axon regeneration | 6.27e-04 | 69 | 50 | 3 | GO:0031103 | |
| GeneOntologyCellularComponent | basal dendrite | 2.59e-04 | 10 | 51 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | NuRD complex | 7.75e-04 | 17 | 51 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 7.75e-04 | 17 | 51 | 2 | GO:0090545 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.42e-08 | 35 | 50 | 5 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 5.26e-08 | 38 | 50 | 5 | PS00690 | |
| Domain | Helicase_C | 3.97e-07 | 107 | 50 | 6 | PF00271 | |
| Domain | HELICc | 3.97e-07 | 107 | 50 | 6 | SM00490 | |
| Domain | Helicase_C | 4.20e-07 | 108 | 50 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 4.44e-07 | 109 | 50 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.44e-07 | 109 | 50 | 6 | PS51192 | |
| Domain | DEXDc | 4.44e-07 | 109 | 50 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.68e-07 | 110 | 50 | 6 | IPR014001 | |
| Domain | SNF2_N | 1.55e-06 | 32 | 50 | 4 | IPR000330 | |
| Domain | SNF2_N | 1.55e-06 | 32 | 50 | 4 | PF00176 | |
| Domain | CHDCT2 | 2.10e-05 | 3 | 50 | 2 | PF08074 | |
| Domain | CHDNT | 2.10e-05 | 3 | 50 | 2 | PF08073 | |
| Domain | DUF1086 | 2.10e-05 | 3 | 50 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.10e-05 | 3 | 50 | 2 | IPR009463 | |
| Domain | CHD_N | 2.10e-05 | 3 | 50 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.10e-05 | 3 | 50 | 2 | IPR012957 | |
| Domain | DUF1087 | 2.10e-05 | 3 | 50 | 2 | PF06465 | |
| Domain | DUF1086 | 2.10e-05 | 3 | 50 | 2 | PF06461 | |
| Domain | DUF1087 | 2.10e-05 | 3 | 50 | 2 | SM01147 | |
| Domain | DUF1086 | 2.10e-05 | 3 | 50 | 2 | SM01146 | |
| Domain | Chromo_domain | 3.51e-05 | 24 | 50 | 3 | IPR023780 | |
| Domain | Chromo | 4.49e-05 | 26 | 50 | 3 | PF00385 | |
| Domain | CHROMO_1 | 5.64e-05 | 28 | 50 | 3 | PS00598 | |
| Domain | CHROMO_2 | 5.64e-05 | 28 | 50 | 3 | PS50013 | |
| Domain | Chromodomain-like | 8.48e-05 | 32 | 50 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 9.31e-05 | 33 | 50 | 3 | IPR000953 | |
| Domain | CHROMO | 9.31e-05 | 33 | 50 | 3 | SM00298 | |
| Domain | Surp | 1.05e-04 | 6 | 50 | 2 | PF01805 | |
| Domain | SWAP | 1.05e-04 | 6 | 50 | 2 | SM00648 | |
| Domain | SURP | 1.05e-04 | 6 | 50 | 2 | PS50128 | |
| Domain | Surp | 1.05e-04 | 6 | 50 | 2 | IPR000061 | |
| Domain | - | 1.42e-04 | 746 | 50 | 9 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 3.68e-04 | 848 | 50 | 9 | IPR027417 | |
| Domain | - | 4.29e-04 | 55 | 50 | 3 | 1.10.30.10 | |
| Domain | HMG_box_dom | 7.02e-04 | 65 | 50 | 3 | IPR009071 | |
| Domain | DSRM | 1.17e-03 | 19 | 50 | 2 | SM00358 | |
| Domain | dsrm | 1.29e-03 | 20 | 50 | 2 | PF00035 | |
| Domain | DS_RBD | 1.43e-03 | 21 | 50 | 2 | PS50137 | |
| Domain | G_patch | 1.71e-03 | 23 | 50 | 2 | SM00443 | |
| Domain | G_patch_dom | 1.71e-03 | 23 | 50 | 2 | IPR000467 | |
| Domain | G_PATCH | 1.71e-03 | 23 | 50 | 2 | PS50174 | |
| Domain | G-patch | 1.71e-03 | 23 | 50 | 2 | PF01585 | |
| Domain | zf-CCHC | 1.71e-03 | 23 | 50 | 2 | PF00098 | |
| Domain | - | 2.19e-03 | 26 | 50 | 2 | 4.10.60.10 | |
| Domain | RRM_1 | 2.31e-03 | 208 | 50 | 4 | PF00076 | |
| Domain | - | 2.36e-03 | 27 | 50 | 2 | 3.30.160.20 | |
| Domain | dsRBD_dom | 2.54e-03 | 28 | 50 | 2 | IPR014720 | |
| Domain | RRM | 2.69e-03 | 217 | 50 | 4 | SM00360 | |
| Domain | RRM_dom | 3.16e-03 | 227 | 50 | 4 | IPR000504 | |
| Domain | RRM | 3.31e-03 | 230 | 50 | 4 | PS50102 | |
| Domain | ZF_CCHC | 3.95e-03 | 35 | 50 | 2 | PS50158 | |
| Domain | - | 4.09e-03 | 244 | 50 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.98e-03 | 258 | 50 | 4 | IPR012677 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.13e-06 | 612 | 34 | 10 | MM15547 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.11e-06 | 724 | 34 | 10 | M16843 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.52e-06 | 201 | 34 | 6 | MM15411 | |
| Pathway | WP_MRNA_PROCESSING | 9.00e-06 | 451 | 34 | 8 | MM15946 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.02e-05 | 212 | 34 | 6 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.62e-05 | 277 | 34 | 6 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 5.20e-05 | 283 | 34 | 6 | M13087 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | 1.88e-04 | 888 | 34 | 9 | M48034 | |
| Pathway | WP_MISMATCH_REPAIR | 2.01e-04 | 9 | 34 | 2 | MM15932 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 3.31e-04 | 254 | 34 | 5 | M27131 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 3.72e-04 | 143 | 34 | 4 | M39591 | |
| Pathway | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | 5.05e-04 | 14 | 34 | 2 | M4280 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER | 7.51e-04 | 17 | 34 | 2 | M47831 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | 8.05e-04 | 1081 | 34 | 9 | M27548 | |
| Pathway | REACTOME_LAGGING_STRAND_SYNTHESIS | 1.04e-03 | 20 | 34 | 2 | MM15374 | |
| Pathway | REACTOME_LAGGING_STRAND_SYNTHESIS | 1.04e-03 | 20 | 34 | 2 | M9461 | |
| Pathway | REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR | 1.15e-03 | 21 | 34 | 2 | M27505 | |
| Pathway | REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR | 1.15e-03 | 21 | 34 | 2 | MM15230 | |
| Pathway | WP_DNA_MISMATCH_REPAIR | 1.38e-03 | 23 | 34 | 2 | M39668 | |
| Pathway | KEGG_MISMATCH_REPAIR | 1.38e-03 | 23 | 34 | 2 | M13515 | |
| Pathway | REACTOME_DNA_STRAND_ELONGATION | 1.51e-03 | 24 | 34 | 2 | MM15375 | |
| Pathway | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | 1.64e-03 | 25 | 34 | 2 | M541 | |
| Pathway | REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER | 1.64e-03 | 25 | 34 | 2 | M27593 | |
| Pathway | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | 1.77e-03 | 26 | 34 | 2 | MM14481 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR | 1.77e-03 | 26 | 34 | 2 | M47827 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.87e-03 | 102 | 34 | 3 | MM15430 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 2.03e-03 | 105 | 34 | 3 | M27425 | |
| Pathway | REACTOME_HIV_INFECTION | 2.21e-03 | 231 | 34 | 4 | M12469 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 2.35e-03 | 30 | 34 | 2 | MM15173 | |
| Pathway | REACTOME_DNA_STRAND_ELONGATION | 2.68e-03 | 32 | 34 | 2 | M19312 | |
| Pathway | REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS | 2.84e-03 | 33 | 34 | 2 | MM14683 | |
| Pathway | REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS | 3.02e-03 | 34 | 34 | 2 | M27030 | |
| Pathway | REACTOME_SYNTHESIS_OF_DNA | 3.04e-03 | 121 | 34 | 3 | M5224 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | POLR1F SMARCA5 ILF3 PSIP1 SFSWAP MAP1B RSL1D1 U2SURP TPX2 RBM7 ANKRD11 GPATCH4 CHD3 RFC1 RRBP1 UBN2 DDX24 RPL5 TOP1 DHX9 KNOP1 | 6.76e-20 | 954 | 51 | 21 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 U2SURP TPX2 RBM7 ANKRD11 RBM5 GPATCH4 CHD3 CHD6 RFC1 TAF5 RRBP1 UBN2 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 7.99e-20 | 1294 | 51 | 23 | 30804502 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 CHD5 U2SURP RBM5 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 8.36e-18 | 605 | 51 | 17 | 28977666 |
| Pubmed | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 U2SURP TPX2 RBM7 RBM5 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 9.99e-17 | 847 | 51 | 18 | 35850772 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1F SMARCA5 PSIP1 MAP1B RSL1D1 NEMF TPX2 GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 3.58e-16 | 759 | 51 | 17 | 35915203 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | POLR1F FCF1 LIG1 SMARCA5 ILF3 RSL1D1 U2SURP PSMC1 GPATCH4 CHD6 RFC1 TAF5 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.33e-14 | 1318 | 51 | 19 | 30463901 |
| Pubmed | FCF1 SMARCA5 ILF3 GZF1 PSIP1 SFSWAP RSL1D1 NEMF TPX2 RBM7 RBM5 GPATCH4 CHD3 MARCKSL1 TRPM1 RFC1 RRBP1 TOP1 KNOP1 | 2.69e-14 | 1371 | 51 | 19 | 36244648 | |
| Pubmed | FCF1 SMARCA5 RSL1D1 U2SURP GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.79e-13 | 483 | 51 | 13 | 36912080 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | POLR1F LIG1 SMARCA5 ILF3 SFSWAP CWC27 RSL1D1 U2SURP TPX2 RBM5 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 | 4.58e-13 | 989 | 51 | 16 | 36424410 |
| Pubmed | ILF3 GZF1 PSIP1 RSL1D1 RBM7 CHD3 TAF5 RPL4 RPL5 TOP1 DHX9 KNOP1 | 7.85e-13 | 417 | 51 | 12 | 36537216 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | ILF3 MAP1B RSL1D1 U2SURP GPATCH4 RFC1 DDX24 RPL4 TOP1 DHX9 KNOP1 | 1.01e-12 | 316 | 51 | 11 | 31665637 |
| Pubmed | ILF3 PSIP1 SFSWAP RSL1D1 U2SURP ZCRB1 GPATCH4 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.31e-12 | 713 | 51 | 14 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 U2SURP RBM7 PSMC1 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.34e-12 | 714 | 51 | 14 | 28302793 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SMARCA5 ILF3 PSIP1 SFSWAP MAP1B U2SURP NEMF RBM7 RBM5 CHD6 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.78e-12 | 1082 | 51 | 16 | 38697112 |
| Pubmed | 2.37e-12 | 102 | 51 | 8 | 26584622 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 U2SURP TPX2 GPATCH4 CHD3 RFC1 RRBP1 RPL4 RPL5 TOP1 KNOP1 | 3.16e-12 | 934 | 51 | 15 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMARCA5 PSIP1 CWC27 CHD5 TPX2 GPATCH4 CHD3 CHD6 RFC1 UBN2 DDX24 TOP1 KNOP1 | 3.25e-12 | 608 | 51 | 13 | 36089195 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | ILF3 RSL1D1 U2SURP NEMF GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 4.69e-12 | 486 | 51 | 12 | 30940648 |
| Pubmed | ILF3 GZF1 RSL1D1 U2SURP GPATCH4 CHD3 CHD6 RFC1 RRBP1 DDX24 RPL4 RPL5 DHX9 | 8.24e-12 | 655 | 51 | 13 | 35819319 | |
| Pubmed | POLR1F GZF1 SFSWAP CWC27 PIEZO1 TPX2 RBM7 ANKRD11 PSMC1 RBM5 GPATCH4 CHD6 MARCKSL1 TAF5 ZHX2 UBN2 KNOP1 | 2.01e-11 | 1497 | 51 | 17 | 31527615 | |
| Pubmed | FCF1 SMARCA5 ILF3 RSL1D1 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 | 2.10e-11 | 419 | 51 | 11 | 15635413 | |
| Pubmed | 2.71e-11 | 215 | 51 | 9 | 30462309 | ||
| Pubmed | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 U2SURP RBM7 GPATCH4 DDX24 RPL4 TOP1 DHX9 KNOP1 | 3.21e-11 | 731 | 51 | 13 | 29298432 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 3.32e-11 | 220 | 51 | 9 | 31822558 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | SMARCA5 ILF3 RSL1D1 CHD5 GPATCH4 CHD3 MARCKSL1 DDX24 TOP1 DHX9 | 4.67e-11 | 330 | 51 | 10 | 33301849 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | POLR1F SMARCA5 ILF3 MAP1B RSL1D1 U2SURP RBM7 PSMC1 GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 5.00e-11 | 1353 | 51 | 16 | 29467282 |
| Pubmed | 5.26e-11 | 334 | 51 | 10 | 30425250 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FCF1 SMARCA5 ILF3 PSIP1 RSL1D1 CHD5 U2SURP TPX2 GPATCH4 RRBP1 RPL4 RPL5 TOP1 DHX9 | 5.84e-11 | 949 | 51 | 14 | 36574265 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIG1 SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 TPX2 RBM7 CHD3 RFC1 RRBP1 DDX24 DHX9 | 6.50e-11 | 774 | 51 | 13 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SMARCA5 ILF3 PSIP1 RSL1D1 U2SURP NEMF PSMC1 RBM5 GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.07e-10 | 1425 | 51 | 16 | 30948266 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ILF3 PSIP1 RSL1D1 U2SURP ZCRB1 RBM7 RBM5 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.09e-10 | 807 | 51 | 13 | 22681889 |
| Pubmed | SMARCA5 ILF3 PSIP1 MAP1B CWC27 RSL1D1 SPEF2 CHD5 U2SURP RBM5 CHD3 CHD6 RRBP1 RPL4 TOP1 KNOP1 | 1.28e-10 | 1442 | 51 | 16 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SMARCA5 ILF3 PSIP1 RSL1D1 CHD5 TPX2 PSMC1 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.03e-10 | 1257 | 51 | 15 | 36526897 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.12e-10 | 271 | 51 | 9 | 32433965 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.63e-10 | 394 | 51 | 10 | 27248496 | |
| Pubmed | 2.99e-10 | 538 | 51 | 11 | 28524877 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | POLR1F ILF3 MAP1B CWC27 RSL1D1 TMEM131 GPATCH4 RRBP1 UBN2 DDX24 RPL5 TOP1 | 4.57e-10 | 724 | 51 | 12 | 36232890 |
| Pubmed | 5.92e-10 | 123 | 51 | 7 | 35583604 | ||
| Pubmed | 6.51e-10 | 205 | 51 | 8 | 27976729 | ||
| Pubmed | BLK SMARCA5 ILF3 CWC27 RSL1D1 CHD5 ZCRB1 PSMC1 CHD3 CHD6 RPL4 RPL5 TOP1 DHX9 | 7.37e-10 | 1153 | 51 | 14 | 29845934 | |
| Pubmed | 7.80e-10 | 441 | 51 | 10 | 31239290 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMARCA5 ILF3 PSIP1 RSL1D1 U2SURP NEMF PSMC1 GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.03e-09 | 1415 | 51 | 15 | 28515276 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.18e-09 | 221 | 51 | 8 | 29991511 | |
| Pubmed | 1.85e-09 | 234 | 51 | 8 | 36243803 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 1.88e-09 | 145 | 51 | 7 | 27049334 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.17e-09 | 148 | 51 | 7 | 32538781 | |
| Pubmed | 2.75e-09 | 503 | 51 | 10 | 16964243 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | ILF3 MAP1B RSL1D1 U2SURP GPATCH4 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 | 3.35e-09 | 678 | 51 | 11 | 30209976 |
| Pubmed | 3.57e-09 | 159 | 51 | 7 | 22751105 | ||
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 4.16e-09 | 90 | 51 | 6 | 30699358 | |
| Pubmed | LIG1 ILF3 PSIP1 RSL1D1 U2SURP TPX2 PSMC1 RBM5 CHD3 RFC1 UBN2 RPL5 TOP1 | 4.76e-09 | 1103 | 51 | 13 | 34189442 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.19e-09 | 283 | 51 | 8 | 30585729 | |
| Pubmed | 9.41e-09 | 103 | 51 | 6 | 32744500 | ||
| Pubmed | SMARCA5 RSL1D1 CHD5 TPX2 PSMC1 GPATCH4 CHD3 CHD6 RFC1 TAF5 ZHX2 UBN2 DDX24 TOP1 | 1.14e-08 | 1429 | 51 | 14 | 35140242 | |
| Pubmed | 1.56e-08 | 112 | 51 | 6 | 28416769 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 1.56e-08 | 604 | 51 | 10 | 37616343 | |
| Pubmed | 1.85e-08 | 615 | 51 | 10 | 31048545 | ||
| Pubmed | SMARCA5 ILF3 MAP1B NEMF PSMC1 TRPM1 RRBP1 RPL4 RPL5 TOP1 DHX9 | 1.91e-08 | 803 | 51 | 11 | 36517590 | |
| Pubmed | SMARCA5 ILF3 U2SURP NEMF GPATCH4 MARCKSL1 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 2.04e-08 | 1247 | 51 | 13 | 27684187 | |
| Pubmed | ILF3 MAP1B RSL1D1 U2SURP RFC1 TAF5 RRBP1 RPL4 RPL5 TOP1 DHX9 | 2.06e-08 | 809 | 51 | 11 | 32129710 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.19e-08 | 626 | 51 | 10 | 33644029 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 U2SURP PSMC1 CHD3 RRBP1 RPL5 TOP1 DHX9 | 2.19e-08 | 1024 | 51 | 12 | 24711643 |
| Pubmed | 2.89e-08 | 333 | 51 | 8 | 36779763 | ||
| Pubmed | 3.20e-08 | 652 | 51 | 10 | 31180492 | ||
| Pubmed | 3.37e-08 | 62 | 51 | 5 | 19710015 | ||
| Pubmed | 3.69e-08 | 223 | 51 | 7 | 20020773 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 3.85e-08 | 665 | 51 | 10 | 30457570 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 4.15e-08 | 349 | 51 | 8 | 25665578 | |
| Pubmed | SMARCA5 ILF3 MAP1B RSL1D1 PSMC1 CHD3 MARCKSL1 RFC1 RRBP1 DDX24 RPL4 RPL5 DHX9 | 4.53e-08 | 1335 | 51 | 13 | 29229926 | |
| Pubmed | 4.99e-08 | 136 | 51 | 6 | 21280222 | ||
| Pubmed | 7.03e-08 | 245 | 51 | 7 | 21182205 | ||
| Pubmed | 7.20e-08 | 72 | 51 | 5 | 12777385 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 7.21e-08 | 375 | 51 | 8 | 32788342 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ILF3 MAP1B RSL1D1 U2SURP NEMF PSMC1 MARCKSL1 RFC1 RPL4 RPL5 TOP1 DHX9 | 7.71e-08 | 1149 | 51 | 12 | 35446349 |
| Pubmed | 8.39e-08 | 723 | 51 | 10 | 34133714 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 8.64e-08 | 384 | 51 | 8 | 31059266 | |
| Pubmed | 9.92e-08 | 551 | 51 | 9 | 34728620 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.33e-07 | 269 | 51 | 7 | 29511261 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.42e-07 | 410 | 51 | 8 | 26949251 | |
| Pubmed | 1.50e-07 | 274 | 51 | 7 | 34244482 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.58e-07 | 582 | 51 | 9 | 20467437 | |
| Pubmed | LIG1 FAT4 SFSWAP RSL1D1 RBM5 GPATCH4 MARCKSL1 RPL4 DHX9 KNOP1 | 1.63e-07 | 777 | 51 | 10 | 35844135 | |
| Pubmed | 1.74e-07 | 421 | 51 | 8 | 34650049 | ||
| Pubmed | SMARCA5 SFSWAP RSL1D1 PSMC1 CCDC80 MARCKSL1 TAF5 RRBP1 TOP1 KNOP1 | 1.82e-07 | 786 | 51 | 10 | 29128334 | |
| Pubmed | 1.87e-07 | 425 | 51 | 8 | 21081503 | ||
| Pubmed | 2.01e-07 | 172 | 51 | 6 | 26336360 | ||
| Pubmed | 2.01e-07 | 286 | 51 | 7 | 32041737 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.05e-07 | 430 | 51 | 8 | 38172120 | |
| Pubmed | 2.06e-07 | 601 | 51 | 9 | 33658012 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.22e-07 | 90 | 51 | 5 | 35654790 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 2.34e-07 | 91 | 51 | 5 | 20362542 | |
| Pubmed | PSIP1 RSL1D1 U2SURP NEMF TPX2 PSMC1 GPATCH4 RFC1 RRBP1 RPL4 TOP1 DHX9 | 2.84e-07 | 1297 | 51 | 12 | 33545068 | |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 3.72e-07 | 191 | 51 | 6 | 21907836 | |
| Pubmed | 3.95e-07 | 469 | 51 | 8 | 37314180 | ||
| Pubmed | 4.13e-07 | 653 | 51 | 9 | 22586326 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.34e-07 | 475 | 51 | 8 | 31040226 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 4.46e-07 | 197 | 51 | 6 | 22365833 | |
| Pubmed | 4.52e-07 | 660 | 51 | 9 | 32780723 | ||
| Pubmed | 5.77e-07 | 109 | 51 | 5 | 29511296 | ||
| Pubmed | 6.42e-07 | 340 | 51 | 7 | 24332808 | ||
| Interaction | SMC5 interactions | POLR1F SMARCA5 ILF3 PSIP1 SFSWAP MAP1B RSL1D1 U2SURP TPX2 RBM7 ANKRD11 GPATCH4 CHD3 RFC1 RRBP1 UBN2 DDX24 RPL5 TOP1 DHX9 KNOP1 | 9.15e-15 | 1000 | 51 | 21 | int:SMC5 |
| Interaction | CHD3 interactions | PTN SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 CHD5 U2SURP RBM5 GPATCH4 CHD3 CHD6 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.04e-14 | 757 | 51 | 19 | int:CHD3 |
| Interaction | HECTD1 interactions | POLR1F SMARCA5 PSIP1 SFSWAP MAP1B RSL1D1 U2SURP NEMF TPX2 ANKRD11 GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 9.01e-14 | 984 | 51 | 20 | int:HECTD1 |
| Interaction | MAGEB2 interactions | FCF1 SMARCA5 ILF3 RSL1D1 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.66e-12 | 349 | 51 | 13 | int:MAGEB2 |
| Interaction | RPL31 interactions | FCF1 ILF3 RSL1D1 U2SURP ZCRB1 ANKRD11 GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 5.67e-12 | 680 | 51 | 16 | int:RPL31 |
| Interaction | ADARB1 interactions | SMARCA5 ILF3 GZF1 RSL1D1 CHD5 U2SURP ZCRB1 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 KNOP1 | 1.16e-11 | 489 | 51 | 14 | int:ADARB1 |
| Interaction | USP36 interactions | FCF1 SMARCA5 ILF3 RSL1D1 U2SURP GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.24e-11 | 599 | 51 | 15 | int:USP36 |
| Interaction | GLYR1 interactions | BLK NEFH ILF3 RSL1D1 ZCRB1 GPATCH4 CHD3 RFC1 RPL4 DHX9 KNOP1 | 1.63e-11 | 239 | 51 | 11 | int:GLYR1 |
| Interaction | RPS6 interactions | ILF3 GZF1 PSIP1 RSL1D1 ZCRB1 TPX2 GPATCH4 CHD3 CHD6 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.14e-11 | 874 | 51 | 17 | int:RPS6 |
| Interaction | RPS19 interactions | SMARCA5 ILF3 GZF1 MAP1B RSL1D1 U2SURP ZCRB1 RBM5 CHD3 RRBP1 DDX24 RPL4 RPL5 TOP1 KNOP1 | 3.10e-11 | 639 | 51 | 15 | int:RPS19 |
| Interaction | ZNF330 interactions | SMARCA5 ILF3 PSIP1 CWC27 RSL1D1 ANKRD11 GPATCH4 CHD3 RFC1 DDX24 RPL5 TOP1 KNOP1 | 5.69e-11 | 446 | 51 | 13 | int:ZNF330 |
| Interaction | CHD4 interactions | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 CHD5 U2SURP RBM5 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 6.48e-11 | 938 | 51 | 17 | int:CHD4 |
| Interaction | DOT1L interactions | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 U2SURP TPX2 RBM7 RBM5 GPATCH4 CHD3 RFC1 DDX24 RPL5 DHX9 KNOP1 | 7.28e-11 | 807 | 51 | 16 | int:DOT1L |
| Interaction | SNRNP70 interactions | SMARCA5 ILF3 PSIP1 SFSWAP MAP1B RSL1D1 U2SURP ZCRB1 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.36e-10 | 984 | 51 | 17 | int:SNRNP70 |
| Interaction | HDLBP interactions | SMARCA5 ILF3 GZF1 PSIP1 SFSWAP TPX2 RBM5 GPATCH4 CHD3 MARCKSL1 TRPM1 RFC1 RRBP1 TOP1 DHX9 KNOP1 | 1.71e-10 | 855 | 51 | 16 | int:HDLBP |
| Interaction | POLR1G interactions | POLR1F LIG1 CWC27 RSL1D1 ANKRD11 GPATCH4 RFC1 UBN2 DDX24 RPL4 RPL5 TOP1 KNOP1 | 1.77e-10 | 489 | 51 | 13 | int:POLR1G |
| Interaction | MEN1 interactions | SMARCA5 ILF3 PSIP1 RSL1D1 U2SURP TPX2 RBM7 RBM5 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.72e-10 | 1029 | 51 | 17 | int:MEN1 |
| Interaction | MYCN interactions | FCF1 SMARCA5 SFRP1 ILF3 PSIP1 SFSWAP MAP1B RSL1D1 U2SURP ZCRB1 RBM7 PSMC1 GPATCH4 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 3.57e-10 | 1373 | 51 | 19 | int:MYCN |
| Interaction | H3C1 interactions | FAT4 SMARCA5 PSIP1 RSL1D1 U2SURP TPX2 GPATCH4 CHD3 RFC1 TAF5 RRBP1 UBN2 DDX24 RPL5 TOP1 KNOP1 | 3.68e-10 | 901 | 51 | 16 | int:H3C1 |
| Interaction | MAFB interactions | 5.04e-10 | 246 | 51 | 10 | int:MAFB | |
| Interaction | RPL11 interactions | FCF1 ILF3 GZF1 MAP1B RSL1D1 NEMF GPATCH4 CHD3 RRBP1 DDX24 RPL4 RPL5 DHX9 KNOP1 | 5.12e-10 | 652 | 51 | 14 | int:RPL11 |
| Interaction | NR2C2 interactions | POLR1F FCF1 LIG1 SMARCA5 ILF3 RSL1D1 U2SURP PSMC1 GPATCH4 CHD6 RFC1 TAF5 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 5.14e-10 | 1403 | 51 | 19 | int:NR2C2 |
| Interaction | NIFK interactions | NEFH ILF3 RSL1D1 ZCRB1 ANKRD11 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 KNOP1 | 5.87e-10 | 431 | 51 | 12 | int:NIFK |
| Interaction | TERF2IP interactions | PSIP1 SFSWAP CWC27 U2SURP TPX2 ANKRD11 RBM5 GPATCH4 CHD3 RFC1 DDX24 TOP1 KNOP1 | 7.80e-10 | 552 | 51 | 13 | int:TERF2IP |
| Interaction | NOP56 interactions | ILF3 RSL1D1 NEMF ANKRD11 GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.15e-09 | 570 | 51 | 13 | int:NOP56 |
| Interaction | IFI16 interactions | FCF1 SMARCA5 ILF3 MAP1B RSL1D1 U2SURP NEMF GPATCH4 RFC1 DDX24 RPL4 TOP1 DHX9 KNOP1 | 1.66e-09 | 714 | 51 | 14 | int:IFI16 |
| Interaction | RPL30 interactions | FCF1 SMARCA5 GZF1 RSL1D1 NEMF PSMC1 GPATCH4 CHD3 DDX24 RPL4 RPL5 KNOP1 | 1.72e-09 | 474 | 51 | 12 | int:RPL30 |
| Interaction | DDX21 interactions | SMARCA5 ILF3 MAP1B RSL1D1 U2SURP ZCRB1 RBM5 GPATCH4 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.78e-09 | 718 | 51 | 14 | int:DDX21 |
| Interaction | RPS16 interactions | ILF3 RSL1D1 U2SURP NEMF ZCRB1 PSMC1 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 DHX9 KNOP1 | 1.98e-09 | 724 | 51 | 14 | int:RPS16 |
| Interaction | DDX23 interactions | SFSWAP MAP1B CWC27 RSL1D1 U2SURP ANKRD11 RBM5 GPATCH4 CHD3 DDX24 TOP1 KNOP1 | 1.99e-09 | 480 | 51 | 12 | int:DDX23 |
| Interaction | CENPA interactions | SMARCA5 PSIP1 ANKRD11 GPATCH4 CHD3 CHD6 RFC1 UBN2 DDX24 TOP1 KNOP1 | 2.07e-09 | 377 | 51 | 11 | int:CENPA |
| Interaction | NPM1 interactions | SMARCA5 ILF3 GZF1 PSIP1 MAP1B RSL1D1 CCDC80 GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.88e-09 | 1201 | 51 | 17 | int:NPM1 |
| Interaction | ELF5 interactions | 3.23e-09 | 147 | 51 | 8 | int:ELF5 | |
| Interaction | SRSF6 interactions | GZF1 RSL1D1 U2SURP ZCRB1 RBM7 RBM5 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 3.36e-09 | 503 | 51 | 12 | int:SRSF6 |
| Interaction | NUP43 interactions | PSIP1 RSL1D1 ANKRD11 GPATCH4 CHD3 CHD6 RFC1 ZHX2 UBN2 DDX24 RPL5 TOP1 KNOP1 | 3.50e-09 | 625 | 51 | 13 | int:NUP43 |
| Interaction | MTDH interactions | ILF3 PSIP1 RSL1D1 SPEF2 CHD3 RRBP1 DDX24 RPL4 RPL5 TOP1 PTHLH DHX9 | 3.52e-09 | 505 | 51 | 12 | int:MTDH |
| Interaction | KAT6A interactions | ILF3 GZF1 PSIP1 RSL1D1 RBM7 CHD3 TAF5 RPL4 RPL5 TOP1 DHX9 KNOP1 | 3.93e-09 | 510 | 51 | 12 | int:KAT6A |
| Interaction | DDRGK1 interactions | FCF1 ILF3 PSIP1 RSL1D1 U2SURP NEMF PSMC1 RBM5 GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 5.20e-09 | 1249 | 51 | 17 | int:DDRGK1 |
| Interaction | RPS8 interactions | ILF3 RSL1D1 U2SURP ZCRB1 PSMC1 RBM5 GPATCH4 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 5.49e-09 | 649 | 51 | 13 | int:RPS8 |
| Interaction | RPS2 interactions | FCF1 ILF3 MAP1B RSL1D1 U2SURP ZCRB1 PSMC1 CHD3 DDX24 RPL4 RPL5 TOP1 KNOP1 | 6.36e-09 | 657 | 51 | 13 | int:RPS2 |
| Interaction | MECP2 interactions | FCF1 SMARCA5 ILF3 PSIP1 SFSWAP MAP1B U2SURP NEMF RBM7 RBM5 CHD6 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 8.15e-09 | 1287 | 51 | 17 | int:MECP2 |
| Interaction | RPL35 interactions | FCF1 ILF3 SFSWAP RSL1D1 U2SURP ZCRB1 GPATCH4 CHD3 DDX24 RPL4 RPL5 KNOP1 | 1.07e-08 | 558 | 51 | 12 | int:RPL35 |
| Interaction | NAA40 interactions | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 U2SURP TPX2 GPATCH4 CHD3 RFC1 RRBP1 RPL4 RPL5 TOP1 KNOP1 | 1.08e-08 | 978 | 51 | 15 | int:NAA40 |
| Interaction | RNF113A interactions | ILF3 GZF1 RSL1D1 U2SURP GPATCH4 CHD3 CHD6 RFC1 RRBP1 DDX24 RPL4 RPL5 DHX9 | 1.18e-08 | 692 | 51 | 13 | int:RNF113A |
| Interaction | ZBTB2 interactions | LIG1 SMARCA5 ILF3 RSL1D1 CHD5 GPATCH4 CHD3 MARCKSL1 DDX24 TOP1 DHX9 | 1.30e-08 | 450 | 51 | 11 | int:ZBTB2 |
| Interaction | RPL13 interactions | FCF1 SMARCA5 ILF3 GZF1 RSL1D1 U2SURP GPATCH4 CHD3 RFC1 DDX24 RPL4 RPL5 KNOP1 | 1.35e-08 | 700 | 51 | 13 | int:RPL13 |
| Interaction | SRSF1 interactions | FCF1 SMARCA5 PSIP1 U2SURP GPATCH4 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 1.36e-08 | 570 | 51 | 12 | int:SRSF1 |
| Interaction | FGFBP1 interactions | 1.48e-08 | 257 | 51 | 9 | int:FGFBP1 | |
| Interaction | RBM4B interactions | 1.75e-08 | 262 | 51 | 9 | int:RBM4B | |
| Interaction | POU5F1 interactions | SMARCA5 ILF3 PSIP1 RSL1D1 CHD5 CHD3 TRPM1 RFC1 UBN2 DDX24 TOP1 DHX9 | 1.77e-08 | 584 | 51 | 12 | int:POU5F1 |
| Interaction | SCARNA22 interactions | 1.84e-08 | 118 | 51 | 7 | int:SCARNA22 | |
| Interaction | RPL13A interactions | ILF3 GZF1 MAP1B RSL1D1 ZCRB1 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 2.02e-08 | 591 | 51 | 12 | int:RPL13A |
| Interaction | ZC3H18 interactions | SMARCA5 ILF3 PSIP1 SFSWAP RSL1D1 U2SURP RBM7 GPATCH4 CHD3 DDX24 RPL4 TOP1 DHX9 KNOP1 | 2.27e-08 | 877 | 51 | 14 | int:ZC3H18 |
| Interaction | RBM28 interactions | 2.40e-08 | 368 | 51 | 10 | int:RBM28 | |
| Interaction | RSL1D1 interactions | ILF3 GZF1 RSL1D1 U2SURP ZCRB1 GPATCH4 CHD3 DDX24 RPL4 RPL5 KNOP1 | 2.46e-08 | 479 | 51 | 11 | int:RSL1D1 |
| Interaction | RPL5 interactions | ILF3 RSL1D1 U2SURP NEMF CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 DHX9 KNOP1 | 2.67e-08 | 606 | 51 | 12 | int:RPL5 |
| Interaction | NSD2 interactions | 2.91e-08 | 278 | 51 | 9 | int:NSD2 | |
| Interaction | ZNF346 interactions | 3.01e-08 | 377 | 51 | 10 | int:ZNF346 | |
| Interaction | KRR1 interactions | 3.16e-08 | 379 | 51 | 10 | int:KRR1 | |
| Interaction | H3C3 interactions | SMARCA5 CWC27 CHD5 TPX2 GPATCH4 CHD3 CHD6 RFC1 DDX24 TOP1 KNOP1 | 3.45e-08 | 495 | 51 | 11 | int:H3C3 |
| Interaction | WDR76 interactions | 3.49e-08 | 383 | 51 | 10 | int:WDR76 | |
| Interaction | RPL4 interactions | FCF1 ILF3 GZF1 RSL1D1 U2SURP ANKRD11 GPATCH4 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 3.79e-08 | 764 | 51 | 13 | int:RPL4 |
| Interaction | DHX8 interactions | 4.44e-08 | 292 | 51 | 9 | int:DHX8 | |
| Interaction | BRD7 interactions | ILF3 RSL1D1 U2SURP NEMF GPATCH4 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 4.61e-08 | 637 | 51 | 12 | int:BRD7 |
| Interaction | SNRNP40 interactions | ILF3 SFSWAP RSL1D1 RBM5 GPATCH4 CHD3 RFC1 ZHX2 UBN2 DDX24 TOP1 KNOP1 | 4.61e-08 | 637 | 51 | 12 | int:SNRNP40 |
| Interaction | RPL19 interactions | ILF3 GZF1 RSL1D1 NEMF ZCRB1 RBM5 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 4.69e-08 | 638 | 51 | 12 | int:RPL19 |
| Interaction | EFTUD2 interactions | SMARCA5 ILF3 PSIP1 CWC27 RSL1D1 U2SURP NEMF PSMC1 GPATCH4 CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 4.71e-08 | 1449 | 51 | 17 | int:EFTUD2 |
| Interaction | PRKRA interactions | 5.25e-08 | 400 | 51 | 10 | int:PRKRA | |
| Interaction | CBX3 interactions | LIG1 SMARCA5 PSIP1 CWC27 CHD5 TPX2 GPATCH4 CHD3 RFC1 UBN2 TOP1 KNOP1 | 5.37e-08 | 646 | 51 | 12 | int:CBX3 |
| Interaction | LMNA interactions | SMARCA5 ILF3 PSIP1 MAP1B CWC27 RSL1D1 U2SURP TPX2 GPATCH4 CHD3 MARCKSL1 RFC1 DDX24 RPL5 TOP1 KNOP1 | 5.88e-08 | 1286 | 51 | 16 | int:LMNA |
| Interaction | RPSA interactions | ILF3 GZF1 RSL1D1 U2SURP ZCRB1 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 | 5.91e-08 | 522 | 51 | 11 | int:RPSA |
| Interaction | RPS3A interactions | SMARCA5 ILF3 RSL1D1 ZCRB1 GPATCH4 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 KNOP1 | 6.25e-08 | 655 | 51 | 12 | int:RPS3A |
| Interaction | NCL interactions | SMARCA5 ILF3 GZF1 RSL1D1 U2SURP CHD3 RFC1 RRBP1 DDX24 RPL4 RPL5 TOP1 DHX9 | 6.31e-08 | 798 | 51 | 13 | int:NCL |
| Interaction | RPS24 interactions | ILF3 PSIP1 RSL1D1 ANKRD11 GPATCH4 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 6.77e-08 | 529 | 51 | 11 | int:RPS24 |
| Interaction | PARP1 interactions | BLK LIG1 SMARCA5 ILF3 PSIP1 CWC27 RSL1D1 U2SURP TPX2 GPATCH4 CHD3 CHD6 RFC1 RPL5 TOP1 KNOP1 | 8.09e-08 | 1316 | 51 | 16 | int:PARP1 |
| Interaction | RPL23AP32 interactions | 8.37e-08 | 87 | 51 | 6 | int:RPL23AP32 | |
| Interaction | NSA2 interactions | 8.98e-08 | 225 | 51 | 8 | int:NSA2 | |
| Interaction | RPL7A interactions | FCF1 ILF3 GZF1 RSL1D1 ZCRB1 GPATCH4 CHD3 DDX24 RPL4 RPL5 TOP1 KNOP1 | 9.24e-08 | 679 | 51 | 12 | int:RPL7A |
| Interaction | IKZF3 interactions | 9.71e-08 | 320 | 51 | 9 | int:IKZF3 | |
| Interaction | BRD2 interactions | 1.01e-07 | 429 | 51 | 10 | int:BRD2 | |
| Interaction | RPL26L1 interactions | 1.05e-07 | 431 | 51 | 10 | int:RPL26L1 | |
| Interaction | EBNA1BP2 interactions | 1.08e-07 | 324 | 51 | 9 | int:EBNA1BP2 | |
| Interaction | RPL10 interactions | SMARCA5 ILF3 PSIP1 MAP1B NEMF GPATCH4 CHD3 DDX24 RPL4 RPL5 DHX9 KNOP1 | 1.33e-07 | 702 | 51 | 12 | int:RPL10 |
| Interaction | RPL18A interactions | 1.48e-07 | 447 | 51 | 10 | int:RPL18A | |
| Interaction | DGCR8 interactions | 1.57e-07 | 242 | 51 | 8 | int:DGCR8 | |
| Interaction | MAK16 interactions | 1.64e-07 | 162 | 51 | 7 | int:MAK16 | |
| Interaction | RPS3 interactions | ILF3 GZF1 MAP1B RSL1D1 U2SURP ZCRB1 RBM5 CHD3 DDX24 RPL4 RPL5 DHX9 | 1.77e-07 | 721 | 51 | 12 | int:RPS3 |
| Interaction | RRS1 interactions | 1.84e-07 | 345 | 51 | 9 | int:RRS1 | |
| Interaction | RBM39 interactions | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 U2SURP RBM7 PSMC1 CHD3 DDX24 RPL4 RPL5 TOP1 DHX9 | 1.92e-07 | 1042 | 51 | 14 | int:RBM39 |
| Interaction | U2SURP interactions | 2.03e-07 | 349 | 51 | 9 | int:U2SURP | |
| Interaction | PUM3 interactions | 2.27e-07 | 254 | 51 | 8 | int:PUM3 | |
| Interaction | SOX2 interactions | SMARCA5 ILF3 PSIP1 MAP1B RSL1D1 RBM7 RBM5 CHD3 CHD6 RFC1 UBN2 DDX24 RPL4 RPL5 TOP1 DHX9 | 2.34e-07 | 1422 | 51 | 16 | int:SOX2 |
| Interaction | MECOM interactions | 2.51e-07 | 358 | 51 | 9 | int:MECOM | |
| Interaction | RRP8 interactions | 2.64e-07 | 259 | 51 | 8 | int:RRP8 | |
| Interaction | REXO4 interactions | 2.80e-07 | 261 | 51 | 8 | int:REXO4 | |
| Interaction | GRB7 interactions | 3.11e-07 | 178 | 51 | 7 | int:GRB7 | |
| Interaction | USP14 interactions | 3.38e-07 | 489 | 51 | 10 | int:USP14 | |
| Interaction | REST interactions | 4.05e-07 | 274 | 51 | 8 | int:REST | |
| Interaction | NEIL1 interactions | 4.28e-07 | 276 | 51 | 8 | int:NEIL1 | |
| Interaction | RPL6 interactions | 4.35e-07 | 637 | 51 | 11 | int:RPL6 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q12 | 3.87e-04 | 26 | 51 | 2 | chr20q12 | |
| Cytoband | 16q24.3 | 1.55e-03 | 52 | 51 | 2 | 16q24.3 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.11e-04 | 12 | 33 | 2 | 1305 | |
| GeneFamily | RNA binding motif containing | 5.86e-04 | 213 | 33 | 4 | 725 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 7.29e-04 | 22 | 33 | 2 | 579 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 9.44e-04 | 25 | 33 | 2 | 74 | |
| GeneFamily | L ribosomal proteins | 3.90e-03 | 51 | 33 | 2 | 729 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.20e-03 | 53 | 33 | 2 | 532 | |
| GeneFamily | AAA ATPases | 4.20e-03 | 53 | 33 | 2 | 413 | |
| GeneFamily | PHD finger proteins | 1.17e-02 | 90 | 33 | 2 | 88 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | SMARCA5 MAP1B AEBP1 RSL1D1 RBM7 CCDC80 GPATCH4 RPL4 RPL5 TOP1 DHX9 | 1.46e-10 | 380 | 51 | 11 | M41703 |
| Coexpression | FISCHER_DREAM_TARGETS | POLR1F SMARCA5 ILF3 PSIP1 CWC27 TPX2 GPATCH4 RFC1 TAF5 TOP1 KNOP1 | 2.04e-06 | 969 | 51 | 11 | M149 |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN | 2.34e-06 | 198 | 51 | 6 | M8768 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.41e-06 | 199 | 51 | 6 | M3197 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP | 2.41e-06 | 199 | 51 | 6 | M5604 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMARCA5 TOX PSIP1 PIEZO1 SPEF2 U2SURP NEMF ANKRD11 CHD3 DDX24 RPL4 RPL5 DHX9 | 3.90e-06 | 1492 | 51 | 13 | M40023 |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 1.10e-05 | 555 | 51 | 8 | M2343 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 1.43e-05 | 761 | 51 | 9 | M11961 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP | 1.83e-05 | 167 | 51 | 5 | M6337 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.89e-05 | 81 | 51 | 4 | M39253 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 2.22e-05 | 612 | 51 | 8 | M4772 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.87e-05 | 90 | 51 | 4 | M39250 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.76e-05 | 194 | 51 | 5 | M39122 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 4.24e-05 | 199 | 51 | 5 | M5607 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | 4.35e-05 | 200 | 51 | 5 | M5812 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 4.35e-05 | 200 | 51 | 5 | M3513 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP | 4.35e-05 | 200 | 51 | 5 | M5602 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 4.35e-05 | 200 | 51 | 5 | M5668 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS | 4.35e-05 | 35 | 51 | 3 | M39296 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 4.68e-05 | 680 | 51 | 8 | MM456 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | POLR1F SMARCA5 RSL1D1 U2SURP ANKRD11 PSMC1 RRBP1 RPL4 RPL5 TOP1 | 6.02e-05 | 1144 | 51 | 10 | MM3843 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SMARCA5 ILF3 PSIP1 RSL1D1 RFC1 TAF5 ZHX2 RPL4 RPL5 TOP1 DHX9 | 6.16e-05 | 1394 | 51 | 11 | M9585 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 6.24e-05 | 519 | 51 | 7 | M3395 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 6.55e-05 | 523 | 51 | 7 | M12707 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 7.46e-05 | 534 | 51 | 7 | MM1054 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3 | 7.75e-05 | 7 | 51 | 2 | M18597 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 8.28e-05 | 543 | 51 | 7 | MM997 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 9.30e-05 | 45 | 51 | 3 | M1369 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 9.30e-05 | 45 | 51 | 3 | MM576 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 1.07e-04 | 242 | 51 | 5 | M2128 | |
| Coexpression | HOFMANN_CELL_LYMPHOMA_UP | 1.13e-04 | 48 | 51 | 3 | M10783 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.13e-04 | 394 | 51 | 6 | MM3724 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.73e-04 | 426 | 51 | 6 | M9516 | |
| Coexpression | GRADE_COLON_VS_RECTAL_CANCER_DN | 1.79e-04 | 56 | 51 | 3 | M9435 | |
| Coexpression | WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2 | 1.89e-04 | 57 | 51 | 3 | M2316 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.09e-04 | 150 | 51 | 4 | M9139 | |
| Coexpression | RAMASWAMY_METASTASIS_DN | 2.09e-04 | 59 | 51 | 3 | M16963 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 2.42e-04 | 62 | 51 | 3 | M1125 | |
| Coexpression | JONES_OVARY_STROMAL | 2.43e-04 | 156 | 51 | 4 | M48352 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 2.55e-04 | 458 | 51 | 6 | M1606 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.68e-04 | 295 | 51 | 5 | M39121 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.80e-04 | 162 | 51 | 4 | M45037 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP | 2.87e-04 | 163 | 51 | 4 | M6763 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 3.06e-04 | 474 | 51 | 6 | M40991 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 3.08e-04 | 304 | 51 | 5 | M39113 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 3.12e-04 | 1399 | 51 | 10 | M535 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 3.39e-04 | 483 | 51 | 6 | MM1012 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 3.44e-04 | 685 | 51 | 7 | MM3782 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 3.47e-04 | 70 | 51 | 3 | MM994 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 4.59e-04 | 77 | 51 | 3 | M40001 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 4.68e-04 | 721 | 51 | 7 | M10237 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 4.94e-04 | 79 | 51 | 3 | M7102 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 5.51e-04 | 82 | 51 | 3 | M39274 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 5.54e-04 | 194 | 51 | 4 | M3321 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 5.87e-04 | 197 | 51 | 4 | M5161 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 5.87e-04 | 197 | 51 | 4 | M3193 | |
| Coexpression | BHATTACHARYA_EMBRYONIC_STEM_CELL | 5.92e-04 | 84 | 51 | 3 | M4282 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP | 5.98e-04 | 198 | 51 | 4 | M5015 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN | 5.98e-04 | 198 | 51 | 4 | M5448 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN | 6.09e-04 | 199 | 51 | 4 | M9504 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 6.09e-04 | 199 | 51 | 4 | M4567 | |
| Coexpression | GSE17721_CTRL_VS_CPG_24H_BMDC_DN | 6.09e-04 | 199 | 51 | 4 | M3772 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN | 6.09e-04 | 199 | 51 | 4 | M4964 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 6.09e-04 | 199 | 51 | 4 | M9853 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 6.09e-04 | 199 | 51 | 4 | M7524 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 6.09e-04 | 199 | 51 | 4 | M5726 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 6.21e-04 | 200 | 51 | 4 | M7613 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP | 6.21e-04 | 200 | 51 | 4 | M4830 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_UP | 6.21e-04 | 200 | 51 | 4 | M4860 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_UP | 6.21e-04 | 200 | 51 | 4 | M4868 | |
| Coexpression | HALLMARK_E2F_TARGETS | 6.21e-04 | 200 | 51 | 4 | M5925 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP | 6.21e-04 | 200 | 51 | 4 | M7872 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN | 6.21e-04 | 200 | 51 | 4 | M6587 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 6.21e-04 | 200 | 51 | 4 | M6513 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP | 6.21e-04 | 200 | 51 | 4 | M8597 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP | 6.21e-04 | 200 | 51 | 4 | M9276 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP | 6.21e-04 | 200 | 51 | 4 | M8860 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 6.21e-04 | 200 | 51 | 4 | M3199 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 6.45e-04 | 202 | 51 | 4 | M11840 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 6.81e-04 | 205 | 51 | 4 | M39302 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 8.48e-04 | 380 | 51 | 5 | M45714 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | POLR1F LIG1 SMARCA5 SFRP1 TOX PSIP1 MAP1B RSL1D1 NEMF TPX2 GPATCH4 TRPM1 RFC1 TAF5 UBN2 TOP1 | 1.63e-07 | 1459 | 51 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SMARCA5 PSIP1 MAP1B NEMF TPX2 ANKRD11 GPATCH4 ZHX2 TOP1 DHX9 | 4.55e-07 | 532 | 51 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | POLR1F LIG1 SMARCA5 SFRP1 TOX PSIP1 RSL1D1 NEMF TPX2 GPATCH4 RFC1 TAF5 UBN2 TOP1 | 9.88e-07 | 1257 | 51 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | PTN POLR1F LIG1 SMARCA5 SFRP1 PSIP1 MAP1B RSL1D1 NEMF GPATCH4 RFC1 TOP1 KNOP1 | 1.25e-05 | 1347 | 51 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | PTN POLR1F LIG1 SMARCA5 SFRP1 PSIP1 RSL1D1 NEMF GPATCH4 RFC1 TOP1 KNOP1 | 1.51e-05 | 1164 | 51 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SMARCA5 SFRP1 TOX PSIP1 MAP1B NEMF TPX2 ANKRD11 CHD6 TRPM1 TOP1 | 1.72e-05 | 983 | 51 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | SFRP1 MAP1B NEMF RBM7 ANKRD11 PSMC1 CCDC80 ZCCHC2 RPL5 DHX9 KNOP1 | 1.90e-05 | 994 | 51 | 11 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.90e-05 | 232 | 51 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | 8.77e-05 | 779 | 51 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.23e-04 | 469 | 51 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | POLR1F LIG1 SMARCA5 TOX PSIP1 RSL1D1 NEMF ZCRB1 TPX2 TOP1 DHX9 | 1.42e-04 | 1241 | 51 | 11 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | POLR1F LIG1 SMARCA5 TOX PSIP1 RSL1D1 NEMF ZCRB1 TPX2 TRPM1 TOP1 DHX9 | 1.44e-04 | 1468 | 51 | 12 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.67e-04 | 493 | 51 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 1.82e-04 | 349 | 51 | 6 | GSM476675_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.52e-04 | 236 | 51 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 2.61e-04 | 373 | 51 | 6 | GSM605781_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | POLR1F LIG1 SMARCA5 SFRP1 PSIP1 MAP1B RSL1D1 GPATCH4 RFC1 TOP1 KNOP1 | 3.38e-04 | 1371 | 51 | 11 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 4.10e-04 | 406 | 51 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.15e-04 | 407 | 51 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.17e-04 | 146 | 51 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_4 | 4.34e-04 | 13 | 51 | 2 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.49e-04 | 413 | 51 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.50e-04 | 149 | 51 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 4.57e-04 | 769 | 51 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 4.62e-04 | 150 | 51 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 5.18e-04 | 989 | 51 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.24e-04 | 277 | 51 | 5 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 5.46e-04 | 790 | 51 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.59e-04 | 281 | 51 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 6.13e-04 | 804 | 51 | 8 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 6.17e-04 | 162 | 51 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 8.24e-04 | 175 | 51 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 8.46e-04 | 308 | 51 | 5 | GSM605775_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.83e-04 | 311 | 51 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.08e-04 | 654 | 51 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | 9.72e-04 | 1080 | 51 | 9 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 9.76e-04 | 81 | 51 | 3 | GSM605781_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 1.08e-03 | 84 | 51 | 3 | GSM476675_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.16e-03 | 192 | 51 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.19e-03 | 498 | 51 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 1.20e-03 | 87 | 51 | 3 | GSM476658_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 1.28e-03 | 89 | 51 | 3 | GSM476660_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.30e-03 | 339 | 51 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.37e-03 | 91 | 51 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.38e-03 | 201 | 51 | 4 | gudmap_developingKidney_e15.5_500_k3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.35e-11 | 197 | 51 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | C_00|World / shred on cell type and cluster | 5.66e-08 | 179 | 51 | 6 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.88e-08 | 185 | 51 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 188 | 51 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.81e-08 | 189 | 51 | 6 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.31e-08 | 191 | 51 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-08 | 192 | 51 | 6 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.40e-08 | 195 | 51 | 6 | febe746099964b9ea9e75f2efc72c962c01f0421 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 164 | 51 | 5 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 187 | 51 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 2.56e-06 | 190 | 51 | 5 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-06 | 190 | 51 | 5 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-06 | 191 | 51 | 5 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-06 | 191 | 51 | 5 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.76e-06 | 193 | 51 | 5 | c3522693439c23830d8a3f20854539ccb7a666e0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 193 | 51 | 5 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.83e-06 | 194 | 51 | 5 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | Control-CD4+_T_naive|Control / Disease condition and Cell class | 2.98e-06 | 196 | 51 | 5 | 10455dd24d4a4466eeecb22949b83085e8333ad2 | |
| ToppCell | CV-Moderate|CV / Virus stimulation, Condition and Cluster | 3.05e-06 | 197 | 51 | 5 | 8747a57ded96175a8365f066101ce2af80c8081d | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.13e-06 | 198 | 51 | 5 | 86f16b1ae6f9b6d36a72071af883eeb7fb73cc2e | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.13e-06 | 198 | 51 | 5 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.13e-06 | 198 | 51 | 5 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 3.21e-06 | 199 | 51 | 5 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-06 | 199 | 51 | 5 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | (5)_Epi_suprabasal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.21e-06 | 199 | 51 | 5 | e1d0fd71b2f3925d02638413f2155db009f103d9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-06 | 199 | 51 | 5 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-06 | 199 | 51 | 5 | 04e5cfb85c681fd3f4c1151062e4a0f460b55d5f | |
| ToppCell | NS-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.21e-06 | 199 | 51 | 5 | e2d0346cc0c45253b1f958e11263f45e09fd38cb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.21e-06 | 199 | 51 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-06 | 199 | 51 | 5 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 200 | 51 | 5 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.28e-06 | 200 | 51 | 5 | 73b91cb66c375b44e852404a4a445cf2b9595aee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Macroglial|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.28e-06 | 200 | 51 | 5 | b09cc353461f2d6b943ecc24db611679378bad2b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Astrocyte|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.28e-06 | 200 | 51 | 5 | 4a6efb1b756995d217aacc38639c1bd40f1fd725 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK|COVID-19_Severe / Disease, condition lineage and cell class | 3.28e-06 | 200 | 51 | 5 | 323cb89add511fbe9896b4df0f1f2b7fdbb6c649 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK|COVID-19_Severe / Disease group, lineage and cell class | 3.28e-06 | 200 | 51 | 5 | 9fc818bf5c9133fc2fece47980e71fd3f8603558 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-06 | 200 | 51 | 5 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-06 | 200 | 51 | 5 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.28e-06 | 200 | 51 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_suprabasal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.28e-06 | 200 | 51 | 5 | 92382ca82da3e435ccbee1c73261d55164d54779 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.28e-06 | 200 | 51 | 5 | f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-06 | 200 | 51 | 5 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 1.79e-05 | 136 | 51 | 4 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 2.56e-05 | 149 | 51 | 4 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 2.56e-05 | 149 | 51 | 4 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-05 | 159 | 51 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 163 | 51 | 4 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 165 | 51 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 165 | 51 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.90e-05 | 166 | 51 | 4 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 167 | 51 | 4 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 167 | 51 | 4 | 53e32d6687a07f486141df9f4ab998af4c03a507 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 167 | 51 | 4 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 167 | 51 | 4 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.18e-05 | 169 | 51 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 171 | 51 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-05 | 171 | 51 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 171 | 51 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.48e-05 | 172 | 51 | 4 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 175 | 51 | 4 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-05 | 175 | 51 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-05 | 175 | 51 | 4 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.79e-05 | 175 | 51 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.79e-05 | 175 | 51 | 4 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 176 | 51 | 4 | fcf324e6402819683f95e0dd94bf1f777c7f4c76 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 176 | 51 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.90e-05 | 176 | 51 | 4 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.90e-05 | 176 | 51 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-05 | 177 | 51 | 4 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-05 | 178 | 51 | 4 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 51 | 4 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-05 | 179 | 51 | 4 | 68ccfe66474d049a926afc21bffa231446becc69 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 51 | 4 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 51 | 4 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-05 | 180 | 51 | 4 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.35e-05 | 180 | 51 | 4 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-05 | 180 | 51 | 4 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.46e-05 | 181 | 51 | 4 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.46e-05 | 181 | 51 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.46e-05 | 181 | 51 | 4 | c029cecbd7182c70b9893d8c86f334c16291a0db | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-05 | 182 | 51 | 4 | c1665cd9b28fec4bfe4e3981d7992d660f37b97f | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 182 | 51 | 4 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.58e-05 | 182 | 51 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.82e-05 | 184 | 51 | 4 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | a740ceffa62175578e6cff62da1f8dfaf40098e5 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.82e-05 | 184 | 51 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.95e-05 | 185 | 51 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.95e-05 | 185 | 51 | 4 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-05 | 185 | 51 | 4 | 6e08e329dfe78818f3df255476492c8b4b0b16e6 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-05 | 186 | 51 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.07e-05 | 186 | 51 | 4 | 53ebc666a41c4697f607967ff3f17b7207ef5f06 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.07e-05 | 186 | 51 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.07e-05 | 186 | 51 | 4 | b999b9bed8357083997cacf5dc64530ddedc056e | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | 61de94c9ba90e7b6780694199c059c798b1488ae | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.07e-05 | 186 | 51 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.07e-05 | 186 | 51 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 3.87e-06 | 188 | 51 | 6 | 4310_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 4.11e-06 | 190 | 51 | 6 | 4307_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 4.24e-06 | 191 | 51 | 6 | 4303_DN | |
| Drug | AC1L9O0B | 4.92e-06 | 2 | 51 | 2 | CID000423843 | |
| Drug | Metribolone | 2.17e-05 | 382 | 51 | 7 | ctd:D015741 | |
| Drug | bis(tri-n-butyltin)oxide | 2.40e-05 | 538 | 51 | 8 | ctd:C005961 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.98e-05 | 179 | 51 | 5 | 4585_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.28e-05 | 188 | 51 | 5 | 6735_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 6.44e-05 | 189 | 51 | 5 | 4271_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A | 6.77e-05 | 191 | 51 | 5 | 2466_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 6.94e-05 | 192 | 51 | 5 | 4311_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.11e-05 | 193 | 51 | 5 | 5088_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 7.11e-05 | 193 | 51 | 5 | 4321_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 4312_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; HL60; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2902_DN | |
| Disease | Autism Spectrum Disorders | 3.63e-04 | 85 | 48 | 3 | C1510586 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 4.30e-04 | 90 | 48 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | facial width measurement | 6.74e-04 | 105 | 48 | 3 | EFO_0007855 | |
| Disease | central corneal thickness | 1.60e-03 | 309 | 48 | 4 | EFO_0005213 | |
| Disease | Neuroblastoma | 2.67e-03 | 47 | 48 | 2 | C0027819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKDGPDKERKEKTKP | 1011 | Q6UB99 | |
| KPEEEVKKLKPKGTK | 186 | Q6UX04 | |
| KKGKKLRDDKQEKPP | 661 | Q8TDI0 | |
| PPEKTKDKGKKGKKD | 86 | Q8IUX7 | |
| LPPKKSKDKLDKKKE | 196 | Q9H116 | |
| GKKAKNPKEEKKPKE | 4531 | Q6V0I7 | |
| NPKEEKKPKEKKKKG | 4536 | Q6V0I7 | |
| GKELEVKKKGGKKEP | 11 | Q5JU67 | |
| KPAKEKPPKKKAQDK | 486 | Q76M96 | |
| EAGKKEKPEKKVKKS | 31 | P21246 | |
| KPKPQAESKKKKKEG | 146 | P21246 | |
| PKKEVAKKEDKTPIK | 656 | P46821 | |
| KTPIKKEEKPKKEEV | 666 | P46821 | |
| PKKEVKKETPPKEVK | 696 | P46821 | |
| KKETPPKEVKKEVKK | 701 | P46821 | |
| KEPKKEIKKLPKDAK | 726 | P46821 | |
| PKEKGKIKVIKKEGK | 776 | P46821 | |
| KGKKGKTKDEPVKKQ | 911 | O60524 | |
| KEKGKKEKGKKKEAP | 91 | Q9GZP8 | |
| PPKKKKKKRRQKEEE | 201 | Q5T3I0 | |
| GLPEKKKKKKVVKEP | 11 | Q1ED39 | |
| KKPAEKKPTTEEKKP | 411 | P36578 | |
| PAKEGKEKKEKPKSK | 521 | P52756 | |
| AKGEVPPKETPKKKK | 76 | P49006 | |
| KKEEAPKKEAPKPKV | 866 | P12036 | |
| PKKEAPKPKVEEKKE | 871 | P12036 | |
| KEQGPTPVEKKKKGK | 186 | Q8TD26 | |
| EKDRLKPKKKEKKDP | 26 | Q9Y324 | |
| KPKKKEKKDPSALKE | 31 | Q9Y324 | |
| KQKENKPGKPRKRKK | 56 | Q12873 | |
| SKKPDKEKPIKEKDK | 6 | P51451 | |
| KKKKIQKKEEKAEPP | 386 | Q12906 | |
| PKETIKKEEKVLPKK | 231 | Q8IY82 | |
| QKKKKTKKPKEPQPE | 836 | Q9GZR7 | |
| PKKEGKAKKPEKEAS | 11 | P18858 | |
| PPPKDKKKKDKDDDG | 586 | Q08211 | |
| EEGKPKKKKPKKDSI | 396 | Q15542 | |
| VIKVKIPKDKDGKPK | 36 | Q9Y580 | |
| GANKKVKKEPPKKKQ | 1296 | Q9C093 | |
| VKKEPPKKKQEDKKP | 1301 | Q9C093 | |
| PKKKQEDKKPKGKSP | 1306 | Q9C093 | |
| KDPPREEEKEKKKKK | 746 | Q12872 | |
| KPEKDKEPRKGKGKS | 1131 | P35251 | |
| PVYEKKPKKEVKKKR | 251 | P46777 | |
| KDDKDKKKKYEPPVP | 16 | P62191 | |
| VKKENGDKKIVPKKK | 216 | Q8N474 | |
| ETKKPPLKKGEKEKK | 186 | O15042 | |
| KKGKPQTEKEKIKKT | 576 | Q9C0B9 | |
| EDKPRKEPDKKEGKK | 241 | O75475 | |
| EGEKEKKPRKKVPKQ | 286 | Q6ZU65 | |
| VEKKGKTKKKEEKPN | 66 | Q9P2E9 | |
| KTKKKEEKPNGKIPD | 71 | Q9P2E9 | |
| KSPEKKPKIKEEAVK | 426 | O76021 | |
| VKPPKKQEEKEKKGK | 1391 | Q92545 | |
| PKKKKKKKDPETYEV | 226 | Q3B726 | |
| KKGKPGKRKEQEKKK | 126 | P12272 | |
| EDDEPPAKGKKKKKK | 576 | Q7Z4N2 | |
| KPKADAKKVPKKPEE | 191 | Q9Y6X8 | |
| GEREPPKKKEKKKKK | 126 | Q8TBF4 | |
| EKKYPQPKGQKKKKI | 2156 | Q92508 | |
| EEKEKAEKKKRGPKP | 1016 | O60264 | |
| KDKKVPEPDNKKKKP | 181 | P11387 | |
| PEPDNKKKKPKKEEE | 186 | P11387 | |
| KPKTPKKKKKKDPNE | 246 | O94900 | |
| KKKKKKDPNEPQKPV | 251 | O94900 | |
| KEKKIKELQKGEVPK | 551 | Q9ULW0 |